Company / Operating Income
Haemonetics Operating Income History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$164.9M
FY2026
5-year range
$156.0M / $221.8M
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#63 of 156
Health Care
What the data says
At $165M, Haemonetics's operating income ranks #63 of 156 in the Health Care sector. Operating Income has fluctuated over the past 9 years, ranging from $56M in FY2017 to $222M in FY2024.
Based on SEC 10-K filings.
$165M in FY2026 with a 5-year CAGR of +15.3%.
Remained stable around $165M over the past 3 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +15.3%
- 10-Year CAGR
- -
Sector benchmark
#63 of 156 in Health CareTop 40% of 156This company $164.9M Sector average $733.1M
▼
-77.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.3%, indicating consistent growth.
- Ranks #63 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2017.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $164.9M | - |
| FY2025 | - | - |
| FY2024 | $221.8M | +34.5% |
| FY2023 | $164.9M | +5.7% |
| FY2022 | $156.0M | +93.2% |
| FY2021 | $80.8M | -10.0% |
| FY2020 | $89.7M | -13.2% |
| FY2019 | $103.4M | +23.7% |
| FY2018 | $83.5M | +48.8% |
| FY2017 | $56.2M | +389.8% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026